» Articles » PMID: 32584447

Penn Medicine Head and Neck Cancer Service Line COVID-19 Management Guidelines

Abstract

Introduction: The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus has altered the health care environment for the management of head and neck cancers. The purpose of these guidelines is to provide direction during the pandemic for rational Head and Neck Cancer management in order to achieve a medically and ethically appropriate balance of risks and benefits.

Methods: Creation of consensus document.

Results: The process yielded a consensus statement among a wide range of practitioners involved in the management of patients with head and neck cancer in a multihospital tertiary care health system.

Conclusions: These guidelines support an ethical approach for the management of head and neck cancers during the COVID-19 epidemic consistent with both the local standard of care as well as the head and neck oncological literature.

Citing Articles

Provision of Palliative Care during the COVID-19 Pandemic: A Systematic Review of Ambulatory Care Organizations in the United States.

Lieneck C, Betancourt J, Daemen C, Eich R, Monty E, Petty M Medicina (Kaunas). 2021; 57(10).

PMID: 34684160 PMC: 8540351. DOI: 10.3390/medicina57101123.


Making the Best of Limited Resources: Improving Outcomes in Head and Neck Cancer.

Fagan J, Noronha V, Graboyes E Am Soc Clin Oncol Educ Book. 2021; 41:1-11.

PMID: 33793315 PMC: 8059263. DOI: 10.1200/EDBK_320923.


New Challenges of Treatment for Locally Advanced Head and Neck Cancers in the Covid-19 Pandemic Era.

Mirestean C, Crisan A, Mitrea A, Buzea C, Iancu R, Iancu D J Clin Med. 2021; 10(4).

PMID: 33557273 PMC: 7915471. DOI: 10.3390/jcm10040587.


Penn Medicine Head and Neck Cancer Service Line COVID-19 management guidelines.

Weinstein G, Cohen R, Lin A, OMalley Jr B, Lukens J, Swisher-McClure S Head Neck. 2020; 42(7):1507-1515.

PMID: 32584447 PMC: 7362039. DOI: 10.1002/hed.26318.

References
1.
Parhar H, Tasche K, Brody R, Weinstein G, OMalley Jr B, Shanti R . Topical preparations to reduce SARS-CoV-2 aerosolization in head and neck mucosal surgery. Head Neck. 2020; 42(6):1268-1272. PMC: 7267296. DOI: 10.1002/hed.26200. View

2.
Xiao R, Ward M, Yang K, Adelstein D, Koyfman S, Prendes B . Increased pathologic upstaging with rising time to treatment initiation for head and neck cancer: A mechanism for increased mortality. Cancer. 2018; 124(7):1400-1414. DOI: 10.1002/cncr.31213. View

3.
Civantos A, Carey R, Lichtenstein G, Lukens J, Cohen R, Rassekh C . Care of immunocompromised patients with head and neck cancer during the COVID-19 pandemic: Two challenging and informative clinical cases. Head Neck. 2020; 42(6):1131-1136. PMC: 7262192. DOI: 10.1002/hed.26165. View

4.
Bauml J, Vinnakota R, Anna Park Y, Bates S, Fojo T, Aggarwal C . Cisplatin versus cetuximab with definitive concurrent radiotherapy for head and neck squamous cell carcinoma: An analysis of Veterans Health Affairs data. Cancer. 2018; 125(3):406-415. PMC: 6886128. DOI: 10.1002/cncr.31816. View

5.
Weinstein G, Cohen R, Lin A, OMalley Jr B, Lukens J, Swisher-McClure S . Penn Medicine Head and Neck Cancer Service Line COVID-19 management guidelines. Head Neck. 2020; 42(7):1507-1515. PMC: 7362039. DOI: 10.1002/hed.26318. View